Selling And Administration Expenses Изменить Дата
Abbott USD 2.69B 10M 2023-12
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Illumina USD 402M 154M 2023-12
Insmed USD 89.53M 1.1M 2023-12
Ironwood Pharmaceuticals USD 38.67M 2.62M 2023-12
J&J USD 5.81B 410M 2023-12
Lexicon Pharmaceuticals USD 32.23M 2.22M 2023-09
MannKind USD 20.54M 3.44M 2023-12
Merck USD 2.75B 272M 2023-12
Moderna USD 470M 28M 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regulus Therapeutics USD 2.64M 298K 2023-09
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Thermo Fisher Scientific USD 1.67B 377M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
United Therapeutics USD 128.6M 1000K 2023-12
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06



Lexicon Pharmaceuticals Коммерческие И Административные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.